SEC Form 4 · accession 0001213900-16-014814
Icagen, Inc. · ICGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy Tyson
Director
Period of report
Jul 7, 2016
Accepted (ET)
Jul 7, 2016 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001518520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1,F2 | $3.50 | Jul 7, 2016 | A | 15,000 | A | Jul 7, 2016 | Jul 6, 2021 | Common Stock | 15,000 | 15,000 | I |
Explanation of responses
- F1The warrants were issued to the reporting person by Icagen, Inc. (the "Company") in a private placement offering of units (the "Units" and each a "Unit") with each Unit being offered at a price of $10,000 per Unit and each Unit including a five year warrant to purchase 1,500 shares of the Company's common stock for each $10,000 investment.
- F2Tyson Revocable Trust owns the securities and Timothy Tyson is the trustee of the Trust.